Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist

AZ Jan Palfijn Gent120 enrolled

Overview

The purpose of this study is to see whether patients triggered with only human Chorion Gonadotropin (hCG) have higher number of Metaphase II oocytes (MII) and implantation rate than patients triggered with hCG combined with Gonadotropin Releasing Hormone (GnRH) agonist.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

120

Conditions

Infertility

Interventions

Decapeptyl DailyDRUG

Decapeptyl 0.2 mg SC once 1day

pregnylDRUG

5000 IU SC

Eligibility

Sex: FEMALEMax age: 38 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Intra-cytoplasmic sperm injection (ICSI) patients below 38 years * 1,2 or 3 rd IVF-cycle Exclusion Criteria: * polycystic ovary syndrome (PCOS) patients * patients with endocrinological diseases or problems

Locations (1)

A Z Jan Palfijn

Ghent, Oost-vlaanderen, Belgium

Outcomes

Primary Outcomes

MII Oocytes

the number of mature oocytes retrieved

Time frame: 3 weeks

Secondary Outcomes

Pregnancy Rate

the number of pregnancies obtained, wich still is the most important issue for the patients

Time frame: 12 weeks

Patients With Cryopreserved Embryos

Time frame: 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.